Exhibit 5.2
[O’Melveny & Myers LLP Letterhead]
November 10, 2022
Sabra Health Care REIT, Inc.
18500 Von Karman Avenue, Suite 550
Irvine, California 92612
Sabra Health Care Limited Partnership
18500 Von Karman Avenue, Suite 550
Irvine, California 92612
| Re: | Registration Statement on Form S-3 |
Ladies and Gentlemen:
We have acted as counsel to Sabra Health Care REIT, Inc., a Maryland corporation (the “Company”), and Sabra Health Care Limited Partnership, a Delaware limited partnership (the “Partnership”), in connection with the preparation of the Registration Statement on Form S-3 (the “Registration Statement”) filed with the Securities and Exchange Commission (the “Commission”) on November 10, 2022 under the Securities Act of 1933, as amended (the “Securities Act”). The Registration Statement relates to the offer and sale from time to time, pursuant to Rule 415 of the General Rules and Regulations of the Commission promulgated under the Securities Act, of an indeterminate amount of the following securities: (i) shares of the Company’s common stock, par value $0.01 per share (the “Common Stock”); (ii) shares of the Company’s preferred stock, par value $0.01 per share (the “Preferred Stock”), in one or more series; (iii) debt securities of the Partnership, in one or more series (the “Debt Securities”), which will be issued pursuant to the indenture dated September 30, 2021 (the “Base Indenture”) entered into among the Partnership, the Company and Wells Fargo Bank, National Association, as trustee (the “Trustee”), filed as Exhibit 4.7 to the Registration Statement, and one or more supplements or officer’s certificates to the Base Indenture establishing the terms of each series of Debt Securities (the “Supplemental Indenture Documents”; the Base Indenture and the applicable Supplemental Indenture Documents are together referred to as the “Indenture”); (iv) guarantees by the Company of the Debt Securities (the “Guarantees”), which will be issued pursuant to the Base Indenture and the applicable Supplemental Indenture Documents; (v) warrants to purchase Common Stock or Preferred Stock (individually or collectively, the “Warrants”) to be issued pursuant to a warrant agreement (the “Warrant Agreement”) between the Company and a warrant agent to be appointed prior to the issuance of Warrants; (vi) rights to purchase Common Stock or Preferred Stock (individually or collectively, the “Rights”) to be issued pursuant to a rights agreement (the “Rights Agreement”) between the Company and a rights agent to be appointed prior to the issuance of Rights; and (vii) units consisting of two or more series of Common Stock, Preferred Stock, Warrants and/or Rights (the “Units”) to be issued pursuant to a unit agreement (the “Unit Agreement”) between the Company and a unit agent to be appointed prior to the issuance of the Units. The Common Stock, Preferred Stock, Debt Securities, Guarantees, Warrants, Rights and Units are collectively referred to herein as the “Securities.”